[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"congenital-cardiomyopathy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:congenital-cardiomyopathy":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100489887","kidsheart-and-brain--early-eeg-surgery-congenital-heart-disease-predict-onset-of-neurodevelopmental-disorders-100489887",false,"NCT05658965","KIDSHEART AND BRAIN : Early EEG Surgery Congenital Heart Disease Predict Onset of Neurodevelopmental Disorders","Intérêt de l'électroencéphalogramme précoce en Chirurgie de Cardiopathie congénitale Pour prédire la Survenue de Troubles du neurodéveloppement","KHB","Inclusion Criteria:\n\n* Child of less than 1 year admitted for cardiac surgery on extracorporal circulation on the CHU of Lille during the study period.\n* Child with congenital cardiopathy with necessity to be operated before 1 year old.\n\nExclusion Criteria:\n\n* Child with no necessity of surgery before 1 year old.\n* Medical history of cardiac surgery.\n* Refusal of consent by the parents.\n* No social security.\n* Child not operated on the CHU of LILLE.","ALL","1 Day","1 Year",{"count":21,"type":22},50,"ESTIMATED","OBSERVATIONAL","Congenital cardiopathy are frequent malformations (1\u002F100 birth). The progress of surgery permit a survival rate at the adult age of more than 90%. The long terms consequences must be taken in account and the nerodevelopmental disorders are in first place (intelectual deficiency, autism spectrum disorders, or attention disorders) and presents in 30 to 60% of the patients (Calmant, 2015). The impact can be important on the scolarity, the studies, the professional activity and finaly on the quality of life of the patients becomming adults.\n\nThe identification of the risk factors on surgery period should permit to propose the most adapted follow-up to the specifics needs of each patients.\n\nOn the scientific plans, the identification of early markers on brain dammage on EEG should permit to better apprehend the physiopathologic mecanisms involved.",[26,27],"Neurodevelopmental Disorders","Congenital Cardiomyopathy",[29,26,27,30],"EEG","Orality Disorders","RECRUITING","2026-04-21",{"date":34,"type":35},"2026-04-24","ACTUAL",{"date":37,"type":35},"2022-10-10",{"date":39,"type":22},"2026-10-13",{"name":41,"class":42},"University Hospital, Lille","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":51,"minAge":52,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":43},"100579012","remote-monitoring-in-pregnant-women-with-congenital-heart-disease-using-wrist-wearables-100579012","NCT06818760","Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables","Single Center Pilot Study of Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables","Inclusion Criteria:\n\nWomen evaluated in the cardio-obstetrics clinic either prepartum, intrapartum, or postpartum with congenital heart disease.\n\n* Congenital heart disease: Based on modified World Health Organization (mWHO) classification of maternal cardiovascular disease group ≥ II.\n\n  * mWHO Class I include mild pulmonary stenosis, uncomplicated patent ductus arteriosus, and repaired shunts, to be excluded.\n  * mWHO Class II includes unoperated atrial septal defect or ventricular septal defect and repaired tetralogy of Fallot.\n  * mWHO Class II-III includes mild left ventricular impairment, valvular heart disease not in class I, repaired aortic coarctation, Marfan without aortic dilation, bicuspid aortic valve with \\\u003C45 mm root, hypertrophic cardiomyopathy.\n  * mWHO Class III includes systemic right ventricle, Fontan circulation, unrepaired cyanotic heart disease, Marfan with aorta 40-45 mm, bicuspid aortic valve with root 45-50 mm, other complex congenital heart disease (such as Shone complex).\n  * mWHO Class IV includes Marfan with \\>45 mm aorta, bicuspid aortic valve with \\> 50 mm aorta, severe systemic ventricular dysfunction (EF\\\u003C30%), severe symptomatic AS or MS, native severe coarctation, all severe pulmonary hypertension patients from any cause.\n* Congenital valvular heart disease:\n\n  * Native valvular heart disease: tricuspid, pulmonary, mitral and aortic with ≥ moderate regurgitation or stenosis by echocardiography.\n  * Bioprosthetic valvular heart disease with ≥ moderate regurgitation or stenosis by echocardiography.\n  * Any mechanical valve prosthesis\n* Congenital Cardiomyopathy\n\n  * Cardiomyopathy with EF \\\u003C 30%\n  * Cardiomyopathy with EF 30-50%\n* Provide Informed consent\n* Age \\> 18 years of age\n\nExclusion Criteria:\n\n* Patients on hemodialysis","FEMALE","18 Years",{"count":21,"type":22},"Congenital heart disease (CHD) includes a wide variety of types of disease, including congenital abnormalities of the heart valves. This can range from bicuspid aortic valve and other aortic valve deformities to more complex disease such as tetralogy of Fallot.\n\nFor many kinds of CHD, the optimal timing of interventions remains unclear. For instance, in tetralogy of Fallot, there is still equipoise about when to offer pulmonary valve replacement (PVR), while in aortic regurgitation, some patients can remain stable for many years.\n\nThe primary focus of this study is to use continuous physiologic data (CPD), obtained using wearable biosensors (a type of biometric monitoring technology), to develop improved biomarkers of disease progression and prognosis from patients with congenital heart disease (CHD) who are pregnant while they are at home as well as looking at patients' experience and interaction with wearable biosensor technology at home.",[56,57,27,58],"Congenital Heart Disease","Congenital Vascular Disorder","Pregnancy Related","2026-02-11",{"date":61,"type":35},"2026-02-13",{"date":63,"type":35},"2025-01-27",{"date":65,"type":22},"2028-12-31",{"name":67,"class":42},"The Cleveland Clinic"]